![](https://webarchive.library.unt.edu/eot2008/20090511132813im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090511132813im_/http://www.cancer.gov/images/spacer.gif)
adozelesin An alkylating agent that bind to the DNA minor groove in a sequence-specific manner and form covalent adducts with adenines, resulting in the inhibition of DNA replication and induction of apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090511132813im_/http://www.cancer.gov/images/spacer.gif)
Code name: | ![](https://webarchive.library.unt.edu/eot2008/20090511132813im_/http://www.cancer.gov/images/spacer.gif) | U-73,975 | | ![](https://webarchive.library.unt.edu/eot2008/20090511132813im_/http://www.cancer.gov/images/spacer.gif) |
Previous: | adenovirus HER2-transduced autologous dendritic cell vaccine, adenovirus vector, adenovirus-interferon-gamma TG1042, ADH-1, adipose-derived regenerative cells | Next: | Adriamycin PFS, Adriamycin RDF, Adrucil, ADVEXIN, AEE788 |
|
![](https://webarchive.library.unt.edu/eot2008/20090511132813im_/http://www.cancer.gov/images/spacer.gif) |